The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Andreas Culora, analyst in the home affairs and social policy group at RAND Europe, highlights the heightened exposure to COVID-19 for children living in poor quality housing.
Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.
Stephen Boyle, TeleTracking UK’s Product Specialist, recently returned to front line Critical Care nursing at East Cheshire NHS Trust in response to COVID-19. Here, he argues that most changes made within the NHS have been driven by necessity and not intentional innovation.
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores the impact that COVID-19 has had on the rapid scaling of new technology-enabled healthcare services.
William Britton, founder of AutonoMe, discusses how we must attempt to draw more people into the caring industry by re-booting the core skills required.
COVID-19 cases and deaths in federal and state prisons are significantly higher than in general US population, according to researchers from the Johns Hopkins Bloomberg School of Public Health.
Research published in the Annals of the American Thoracic Society has found that Black individuals are twice as likely, as White individuals, to test positive for COVID-19.
The #PayUp movement has called attention to the multi-billion dollar fashion brands who exploit Bangladeshi garment workers and have capitalised from underpaid UK garment workers.
Luke Rodgers, Director of Strategy at the Care Leaders and Julie Tyas, registered social worker and Senior Strategy Lead at Servelec, explore how the language used in a young person’s care record can impact their future.
EIB and CureVac have signed a €75m loan agreement to develop a large-scale production of vaccines, including CureVac's vaccine candidate against SARS-CoV-2.
There is no doubt that the COVID-19 pandemic has largely affected the fashion industry from the people it employs to the waste it has created, however this crisis could present an opportunity to rethink the industry.
